Physician profile
Barbara Ferrell
NPI 1467741397
$4,058.44
in general payments reported to CMS, 2019-2025
14 companies · $664 in 2025
The $664 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $815 · 2022: $1,309 · 2023: $347 · 2024: $924 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,935.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,031.46 | 2021-2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $863.47 | 2021-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $705.61 | 2021-2025 | Ingrezza |
| Alkermes, INC. | $583.91 | 2022-2025 | Lybalvi, Vivitrol, Aristada |
| Teva Pharmaceuticals USA, INC. | $263.05 | 2022-2023 | Austedo Xr, Austedo |
| Genzyme Corporation | $125.20 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $116.70 | 2022 | |
| Hologic Sales and Service, LLC | $96.13 | 2024 | Aptima |
| Lundbeck LLC | $77.62 | 2021 | |
| Indivior INC. | $56.22 | 2021-2025 | Sublocade |
| Braeburn INC. | $53.25 | 2023-2024 | Brixadi |
| Bausch Health US, LLC | $39.93 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $29.74 | 2021-2022 | |
| Alfasigma USA, INC. | $16.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Ferrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.